|
CN106715454B
(zh)
|
2014-07-24 |
2020-06-16 |
格雷斯公司 |
烟酰胺核苷的结晶形式
|
|
KR102629310B1
(ko)
*
|
2015-03-09 |
2024-01-24 |
더블유.알. 그레이스 앤드 캄파니-콘. |
니코틴아미드 리보사이드의 결정 형태
|
|
JP6949002B6
(ja)
|
2015-08-05 |
2021-11-17 |
メトロ インターナショナル バイオテック，エルエルシー |
ニコチンアミドモノヌクレオチド誘導体及びそれらの使用
|
|
EP3347024A2
(en)
*
|
2015-09-08 |
2018-07-18 |
Ecole Polytechnique Federale de Lausanne (EPFL) |
Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders
|
|
GB2542881B
(en)
|
2015-10-02 |
2020-01-01 |
Carr Andrew |
Crystal forms of ß-nicotinamide mononucleotide
|
|
US10611790B2
(en)
|
2015-11-02 |
2020-04-07 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
|
CN115176998A
(zh)
|
2016-04-14 |
2022-10-14 |
可劳迈戴斯有限公司 |
烟酰胺核苷、烟酸核苷、烟酰胺单核苷酸和烟碱基化合物衍生物在婴儿配方中的用途
|
|
GB2553001A
(en)
*
|
2016-08-19 |
2018-02-21 |
The Queen's Univ Of Belfast |
Lactone intermediates of nicotinamide riboside and nicotinate riboside
|
|
BR112019003579A2
(pt)
|
2016-08-22 |
2019-05-21 |
Elysium Health, Inc. |
Composições de ribosídeo de nicotinamida e pterostilbeno e métodos para o tratamento dedistúrbios neurodegenerativos
|
|
CA3045876A1
(en)
|
2016-11-11 |
2018-05-17 |
The Queen's University Of Belfast |
Scalable syntheses of nicotinoyl ribosides and reduced nic otinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
MX2019006278A
(es)
|
2016-11-29 |
2019-08-21 |
Univ Iowa Res Found |
Uso de precursores de nad para mejorar la salud materna y/o salud de la descendencia.
|
|
WO2018132833A1
(en)
*
|
2017-01-13 |
2018-07-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating hypertension and arterial stiffness
|
|
US20180303861A1
(en)
*
|
2017-04-24 |
2018-10-25 |
Eric Marcotulli |
Treating and preventing kidney damage
|
|
US20200085849A1
(en)
*
|
2017-05-18 |
2020-03-19 |
Elysium Health, Inc. |
Methods and compositions for improving sleep
|
|
EP3642214A2
(en)
|
2017-06-19 |
2020-04-29 |
Gangadhara Ganapati |
Nicotinamide riboside derivatives and their uses
|
|
US20200108043A1
(en)
*
|
2017-06-21 |
2020-04-09 |
Yale University |
Compounds and compositions for extending lifespan of a subject
|
|
JP2020526511A
(ja)
*
|
2017-06-30 |
2020-08-31 |
エリジウム・ヘルス・インコーポレイテッド |
ニコチンアミドリボシドの合成方法
|
|
KR101982923B1
(ko)
*
|
2017-07-05 |
2019-05-27 |
가천대학교 산학협력단 |
편두통 진단용 바이오마커 및 상기 바이오마커를 이용한 편두통 진단방법
|
|
KR101990681B1
(ko)
*
|
2017-07-05 |
2019-06-18 |
가천대학교 산학협력단 |
편두통 진단용 바이오마커 및 상기 바이오마커를 이용한 편두통 진단방법
|
|
EP3727400A4
(en)
*
|
2017-12-22 |
2021-10-20 |
Elysium Health, Inc. |
CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
|
|
WO2019133815A1
(en)
*
|
2017-12-28 |
2019-07-04 |
Kansas State University Research Foundation |
Nicotinamide riboside treatments of domesticated meat animals
|
|
US11180521B2
(en)
|
2018-01-30 |
2021-11-23 |
Metro International Biotech, Llc |
Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
|
|
CN110283221A
(zh)
*
|
2018-03-19 |
2019-09-27 |
药源药物化学（上海）有限公司 |
杂环化合物的制备和纯化方法
|
|
WO2019209840A1
(en)
*
|
2018-04-23 |
2019-10-31 |
Elysium Health, Inc. |
Methods and compositions for treating rheumatoid arthritis
|
|
CN110452277A
(zh)
*
|
2018-05-07 |
2019-11-15 |
明特奇点医疗科技(成都)有限公司 |
一种烟酰胺核糖的制备方法
|
|
BR112020023588A2
(pt)
*
|
2018-05-18 |
2021-02-09 |
F. Hoffmann-La Roche Ag |
método para a produção de brometo de b-d-ribofuranosídeo de nicotinamida cristalino de fórmula o-ia, método, para a produção de sais de ¿-d-ribofuranosídeo de (tio)nicotinamida cristalinos, método para a produção de uma composição compreendendo um sal amorfo de ¿-d-ribofuranosídeo de (tio)nicotinamida, brometo de 2,3,5-tri-o-acetil-¿-d-ribofuranosídeo de nicotinamida cristalino de fórmula o-va, brometo de ¿-d-ribofuranosídeo de nicotinamida ou de tionicotinamida cristalino de fórmulas o-ia e s-ia, composição, uso de um composto ¿-d-ribofuranosídeo de (tio)nicotinamida cristalino, composição farmacêutica, método para a produção de brometo de tri-o-acil-¿-d-ribofuranosídeo de fórmula iii, método para remoção de grupos acila de brometo de 2,3,5-tri-o-acil-¿-d-ribofuranosídeo de nicotinamida de fórmula o-va ou de cloreto de 2,3,5-tri-o-acil-¿-d-ribofuranosídeo de nicotinamida de fórmula o-vb
|
|
BR112020023132A2
(pt)
|
2018-06-21 |
2021-02-09 |
Société des Produits Nestlé S.A. |
composições e métodos que usam um precursor de nicotinamida adenina dinucleotídeo (nad+) e pelo menos uma cetona ou um precursor de cetona
|
|
CN108774278A
(zh)
*
|
2018-09-10 |
2018-11-09 |
张洪喜 |
一种制备尼克酰胺核苷盐的方法
|
|
US20210393621A1
(en)
|
2018-10-26 |
2021-12-23 |
The Research Foundation For The State University Of New York |
Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
|
|
EP3897666A2
(en)
|
2018-12-17 |
2021-10-27 |
Mitopower LLC |
Nicotinyl riboside compounds and their uses
|
|
US10618927B1
(en)
|
2019-03-22 |
2020-04-14 |
Metro International Biotech, Llc |
Compositions and methods for modulation of nicotinamide adenine dinucleotide
|
|
US11939348B2
(en)
|
2019-03-22 |
2024-03-26 |
Metro International Biotech, Llc |
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
|
|
US20200397807A1
(en)
|
2019-06-18 |
2020-12-24 |
MitoPower, LLC |
Nicotinyl riboside compounds and their uses
|
|
EP3999518A2
(en)
|
2019-07-19 |
2022-05-25 |
Biosynth AG |
Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
|
|
WO2021084559A1
(en)
*
|
2019-11-01 |
2021-05-06 |
Celagenex Research (India) Pvt. Ltd. |
Synergistic nutritional compositions for treating cerebrovascular diseases
|
|
EP4117680A1
(en)
*
|
2020-03-09 |
2023-01-18 |
Société des Produits Nestlé S.A. |
Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of lung diseases and conditions
|
|
CN111454311B
(zh)
*
|
2020-04-03 |
2021-10-19 |
深圳市迪克曼科技开发有限公司 |
烟酰胺核糖的有机酸盐及其组合物与制备方法
|
|
CN113518782B
(zh)
*
|
2020-06-19 |
2023-09-08 |
邦泰生物工程(深圳)有限公司 |
一种以烟酰胺为原料制备烟酰胺单核苷酸的方法
|
|
CN111808156A
(zh)
*
|
2020-07-15 |
2020-10-23 |
许昌远志生物科技有限公司 |
一种β-烟酰胺核糖氯化物的晶型1A、晶型1B及其制备方法
|
|
US20230263817A1
(en)
*
|
2020-08-28 |
2023-08-24 |
University Of Washington |
High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
|
|
CN112028954B
(zh)
*
|
2020-09-14 |
2022-04-29 |
浩宇康宁健康科技（湖北）有限公司 |
烟酰胺核糖的制备方法
|
|
WO2022157173A1
(en)
|
2021-01-19 |
2022-07-28 |
Biosynth Ag |
Method of making nicotinamide ribofuranoside salts by salt metathesis, the crystalline form of its tosylate salt and the co-crystallized form of its chloride:iodide salt
|
|
AU2022214447A1
(en)
*
|
2021-01-29 |
2023-08-10 |
ChromaDex Inc. |
Ethyl cellulose based coatings for microencapsulation of nicotinamide riboside and other nicotinyl riboside compounds
|
|
WO2022251491A1
(en)
|
2021-05-27 |
2022-12-01 |
Metro International Biotech, Llc |
Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
|
|
CN113943333B
(zh)
*
|
2021-10-09 |
2023-07-14 |
广东生命源科技有限公司 |
一种氢化烟酰胺核糖的制备方法及应用
|
|
CN118176006A
(zh)
*
|
2021-10-27 |
2024-06-11 |
益力舒健康公司 |
治疗更年期综合征的方法
|
|
WO2023147161A2
(en)
*
|
2022-01-31 |
2023-08-03 |
New Frontier Bio, Inc. |
Nicotinate and nicotinamide riboside-based compounds and derivatives thereof
|
|
CN114577935B
(zh)
*
|
2022-03-03 |
2024-07-23 |
中科谱研（北京）科技有限公司 |
一种胶囊中烟酰胺核糖氯化物的分离检测方法
|
|
KR20240161799A
(ko)
*
|
2022-03-15 |
2024-11-12 |
크로마덱스 아이엔씨. |
결정질 베타 니코틴아미드 리보시드 트리아세테이트 클로라이드의 생산 방법
|
|
CN114933621A
(zh)
*
|
2022-04-13 |
2022-08-23 |
深圳市迪克曼生物科技有限公司 |
烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途
|
|
CN115287278B
(zh)
*
|
2022-06-17 |
2023-11-10 |
武汉真福医药股份有限公司 |
一种枯草芽孢杆菌纤溶酶及其制备方法和抗氧化溶血栓组合物
|
|
WO2024160239A1
(zh)
|
2023-02-01 |
2024-08-08 |
博迪贺康(北京)生物技术有限公司 |
一种化合物及其应用
|
|
CN116655528B
(zh)
*
|
2023-04-28 |
2025-12-02 |
宁波百思佳医药科技有限公司 |
一种氯化1-甲基烟酰铵的制备方法
|
|
WO2024259359A2
(en)
|
2023-06-14 |
2024-12-19 |
ChromaDex Inc. |
Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof
|